Cumulus is the first oncology drug development accelerator in Europe. It develops new oncology treatments that target the unmet medical needs of specific cancer patient populations.
Founded by a team with in-dept oncology expertise and proven commercial success, Cumulus brings a powerful, innovative ‘hub and spoke’ approach to the European market for the first time. After a rigorous two-year long asset search, focusing on key molecular vulnerabilities and scientific credentials, Cumulus has curated and created a number of oncology biotech spin-out companies, with other opportunities under review.
Founded by a team with in-dept oncology expertise and proven commercial success, Cumulus brings a powerful, innovative ‘hub and spoke’ approach to the European market for the first time. After a rigorous two-year long asset search, focusing on key molecular vulnerabilities and scientific credentials, Cumulus has curated and created a number of oncology biotech spin-out companies, with other opportunities under review.
Location: United States, Maryland, Lothian
Employees: 11-50
Total raised: $19.14M
Founded date: 2017
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 08.01.2024 | Seed | $11.44M | - |
| 22.02.2022 | - | $5.56M | - |
| 13.07.2020 | - | $2.13M | - |
Mentions in press and media 20
| Date | Title | Description |
| 26.08.2024 | Cumulus Oncology licenses drug candidates developed with leadXpro | In July 2023, Cumulus Oncology, the oncology-focused biotech creation company based in Edinburgh, and LXP, based at Park Innovaare in Villigen (AG), announced a collaboration to develop small molecules against GPR68, an important proton se... |
| 07.02.2024 | DIGIT Deal Roundup | January 2024 | Welcome to the latest edition of the DIGIT Deal Roundup. Scotland’s tech sector jumped right back to work in January, with a swath of new investment, funding, and acquisition news across the industry. For a recap on those standout stories, ... |
| 08.01.2024 | Cumulus Oncology Raises £9M in Seed Financing | Cumulus Oncology, an Edinburgh, Scotland, UK-based oncology biotech company, raised £9M in Seed funding. The round was led by Eos Advisory and the Scottish National Investment Bank. The company intends to use the funds to execute growth pla... |
| 08.01.2024 | Scotland-based Cumulus Oncology raised GBP 9 million in seed funding | Edinburgh, Scotland-based Cumulus Oncology company operating in th3 Europe’s first oncology biotech creation business model raised GBP 9 million in seed financing. The company announced the fundraise on January 8, 2023. Existing investor Eo... |
| 08.01.2024 | Cumulus Oncology raises £9m in seed financing | - |
| 08.01.2024 | Cumulus Oncology Lands £9 Million in Seed Financing | Cumulus Oncology, a biotech creation studio and drug discovery accelerator specialising in oncology, has raised £9 million in seed financing led by existing investor Eos Advisory and with participation from the Scottish National Investment ... |
| 23.08.2023 | Cumulus and leadxpro collaborate to develop cancer drugs | |
| 08.03.2023 | DIGIT Deal Roundup | February 2023 | Welcome to the latest edition of the DIGIT Deal Roundup column, featuring some of the top investment, acquisition and expansion news stories from February, 2023. Scotland’s digital technology sector saw a number of notable deals across the ... |
| 07.02.2023 | Edinburgh BioTech Nodus Oncology Secures £2.4m Funding | Nodus Oncology, a biotech company based in Edinburgh, announced it has raised £2.4 million from new investor KHAN Technology Transfer Fund I (KHAN-I) as well as Cumulus Oncology. The company is focused on developing molecules that inhibit n... |
| 08.04.2022 | DIGIT Movers and Shakers | March 2022 | Recruitment Hamilton Forth Hamilton Forth, a part of the Livingston James Group, has strengthened its team of digital and technology recruiters with the appointment of two new consultants, Lynne Munro and Hazel Swan. Munro and Swan join the... |
Show more